- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01245868
Spinal Anaesthesia for Knee Arthroscopy: Does Lignocaine Shorten the Effect of Bupivacaine
May 7, 2015 updated by: Jon Jacobsen, Frederikssunds Hospital, Denmark
Spinal Anaesthesia for Knee Arthroscopy: Does Lignocaine Shorten the Effect of Bupivacaine?
The purpose of the study is to investigate if a small amount of lignocaine added to bupivacaine for spinal anesthesia to patients planned for arthroscopic knee surgery, can shorten the duration of the sensoric and the motoric blockade.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Frederikssund, Denmark, 3600
- Dep. of anesthesiology, Hospital of Frederikssund
-
Frederikssund, Denmark, DK 3600
- Jon Jacobsen
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- The patient want spinal anaesthesia
- No contradictions against spinal anaesthesia
- Healthy people (ASA-score 1 or 2)
- Body mass index < 35 and between 155 and 190 cm
Exclusion Criteria:
- Known allergic reactions to planned drugs
- Neurologic disturbances
- Diabetes
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Bupivacaine
Bupivacaine as used routinely
|
|
Placebo Comparator: Lidocaine added to bupivacaine
lidocaine is added to bupivacaine
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Duration of spinal blockade
Time Frame: Repeating monitoring every 15 minutes after applying the blockade, up to 360 minutes.
|
Repeating monitoring every 15 minutes after applying the blockade, up to 360 minutes.
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Time to fulfillment of discharge criteria from the hospital.
Time Frame: Evaluated every 15 minutes after the operation up to 360 minutes. On average 200 to 300 minutes.
|
Evaluated every 15 minutes after the operation up to 360 minutes. On average 200 to 300 minutes.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Jon Jacobsen, M.D., Frederikssunds Hospital, Denmark
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2009
Primary Completion (Actual)
December 1, 2010
Study Completion (Actual)
December 1, 2010
Study Registration Dates
First Submitted
June 14, 2010
First Submitted That Met QC Criteria
November 22, 2010
First Posted (Estimate)
November 23, 2010
Study Record Updates
Last Update Posted (Estimate)
May 8, 2015
Last Update Submitted That Met QC Criteria
May 7, 2015
Last Verified
May 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Anti-Arrhythmia Agents
- Central Nervous System Depressants
- Peripheral Nervous System Agents
- Sensory System Agents
- Anesthetics
- Membrane Transport Modulators
- Anesthetics, Local
- Voltage-Gated Sodium Channel Blockers
- Sodium Channel Blockers
- Lidocaine
- Bupivacaine
Other Study ID Numbers
- FRS-AN2009-03-09
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Spinal Anesthesia
-
Samsung Medical CenterCompletedSpinal Anesthesia | Success or Failure of Spinal AnesthesiaKorea, Republic of
-
University of Alabama at BirminghamCompleted
-
Universidade do Vale do SapucaiCompletedAnesthesia, Epidural | Anesthesia, Spinal | AntisepsisBrazil
-
San Salvatore Hospital of L'AquilaRecruitingAnesthesia, Local | Anesthesia; Functional | Spinal CordItaly
-
Antalya Training and Research HospitalCompletedAnesthesia, General | Anesthesia, Spinal | Umbilical CordTurkey
-
Ankara City Hospital BilkentNot yet recruiting
-
Seoul National University HospitalCompletedAnesthesia, SpinalKorea, Republic of
-
University Health Network, TorontoCompletedSpinal AnesthesiaCanada
-
Guangzhou General Hospital of Guangzhou Military...Completed
-
National Taiwan University HospitalUnknown
Clinical Trials on Lidocaine
-
Ohio State UniversityCompleted
-
Khon Kaen UniversityNot yet recruitingIntubation | Hemodynamics | Laryngoscopy | Neurosurgery | LidocaineThailand
-
Aswan University HospitalUnknown
-
Benha UniversityCompletedPostcesarean Pain Relief
-
McMaster UniversitySt. Joseph's Healthcare HamiltonWithdrawnIntravenous Lidocaine for Post-Operative Pain Control in Patients Undergoing Bariatric Bowel SurgeryBariatric Surgery Candidate
-
Scilex Pharmaceuticals, Inc.Completed
-
Scilex Pharmaceuticals, Inc.Completed
-
Oregon Health and Science UniversityCompleted
-
Chung-Ang University Hosptial, Chung-Ang University...UnknownPostoperative PainKorea, Republic of
-
Hopital FochCompleted